KURA ONE, Compact Cans of Japanese Sake Featuring Brands From Award-winning Sake Breweries in Japan and Overseas, Is Now Available as a Subscription Service Delivered Worldwide!
28.2.2023 11:00:00 EET | Business Wire | Press release
KURA ONE meticulously selects sake from brands of award-winning sake breweries in Japan and overseas and repackages them in compact and easy-to-handle 180ml/196g aluminum cans, while maintaining the quality of the sake. On January 31, the first canned sake subscription service in the world that delivers sake, along with stories about enjoying sake, directly to customers via subscription in more than 100 countries has launched online ordering. As a result of the service's introduction in numerous media sources, it has been attracting attention in Japan.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230223006067/en/
Sake breweries from different regions also participated in the press conference. (Photo: Business Wire)
“KURA ONE Sales Commemorative Special Edition,” which is a complete set of all 21 brands to be delivered from January to June 2023, and the Assortment Box with special sake containers featuring Japanese craftsmanship are very popular.
Also, KURA ONE's brand movie "KURA ONE TRIP." which introduces sake breweries and their regions is now online. On February 28 (Tue.), KURA ONE begins accepting applications worldwide for BtoB partners (restaurants, sake retailers, etc.) who can place orders for as little as 30 cans.
Video of press conference in Tokyo (English version): https://www.youtube.com/watch?v=aTTeue_Y2Ig
KURA ONE TRIP.: https://sake.japanpage.jp/en/pages/kuraone_movies
[Six new Collections. Now shipping to 100 countries around the world!]
-
“KURA ONE STORY. Subscription”: 3-4 cans of brands from domestic and international award-winning sake breweries delivered each month.
Price: 3,600 yen (tax not included) per month, limited to the first 2,000 slots - “KURA ONE Sales Commemorative Special Edition”: a special complete set of 21 cans of brands from award-winning sake breweries in Japan and overseas. Price: 23,000 yen (without tax) and limited to the first 500 sets.
- "KURA ONE Glass Sake Cup Box": includes 4 types of sake glasses of Kimoto Glassware used in famous restaurants, and 2 cans of KURA ONE. Price: 16,800 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Traditional Craft Sake Cup Box": includes 3 types of traditional craft sake vessels such as Ceramic (Shigaraki) and Porcelain (Kutani) and 2 cans of KURA ONE. Price: 7,600 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Temperature Sensitive Sake Cups Box": includes 2 mysterious sake vessels whose cherry blossom color changes depending on the sake temperature, and 2 cans of KURA ONE. Price: 5,400 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Gacha Box": an experimental box for starters. You will enjoy 2 cans of KURA ONE after they arrive. Price: 1,700 yen (without tax)
- Shipping fees and taxes not included.
Click here to purchase (on the official website):
English: https://sake.japanpage.jp/en/pages/kuraone
French: https://sake.japanpage.jp/fr/pages/kuraone
Traditional Chinese: https://sake.japanpage.jp/zh-tw/pages/kuraone
Simplified Chinese: https://sake.japanpage.jp/zh-cn/pages/kuraone
Japanese: https://sake.japanpage.jp/pages/kuraone
[Now accepting applications for BtoB partners worldwide]
We are seeking BtoB sales partners to create new sake drinking scenes that integrate with the lifestyles of consumers in various parts of the world.
KURA ONE places importance on its target users and sales method. We will interview each company to make decisions based on the proposal content and their enthusiasm for the project, rather than on a first-come, first-served basis. This is not an exclusive offer for one company in one country. Currently, we have begun to conclude business negotiations with restaurants and sake retailers in Asia, Europe, and the United States.
Overview of BtoB sales partnerships / Transaction details / Privileges / How to apply (5 languages): https://sake.japanpage.jp/en/pages/kuraone_btob
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223006067/en/
Contact information
KURA ONE
Public Relations: Tomoko Takiguchi
+81-80-8422-5844
info@greencreate.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
